A Study To Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving CP-690,550 Or Placebo
Condition: Rheumatoid Arthritis Interventions: Drug: CP-690,550; Drug: placebo Sponsor: Pfizer Not yet recruiting - verified July 2011